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through 10 months.
Results: Median TpP levels were 8.9 ug/ml (IQR 4.8-15.9). Higher baseline levels of TpP
were associated with older age, hypertension, diabetes, prior CAD, and prior CHF
(p<0.05 for each). TpP levels correlated only weakly with troponin I (TnI), C-reactive pro-
tein (CRP), and B-type natriuretic peptide (BNP) (|r|<0.1 for each). The risk of death, MI,
Urg Revasc, Sev Isch, and the composite increased progressively with rising levels of
TpP (Fig). After adjusting for baseline differences, including TnI, CRP, and BNP, patients
with TpP levels above the median remained at significantly increased risk for the com-
posite endpoint (hazard ratio 1.47, p=0.001).
Conclusion: In patients with ACS, elevated levels of TpP at baseline are associated with
an increased risk of death and ischemic complications. These data support the value of
combining a marker of active thrombosis, such as TpP, with established biomarkers of
necrosis, inflammation, and hemodynamic stress for risk assessment in ACS.
11:30 a.m.
884-5 Impact of Troponin Status and Coronary Artery Disease 
by Angiography on Outcome in Acute Coronary 
Syndrome: A TACTICS TIMI-18 Substudy
Manu Pillai, Peter DiBattiste, Sabina Murphy, David Morrow, Christopher Cannon, Nasser 
M. Lakkis, Baylor College of Medicine, Houston, TX, Brigham and Women's Hospital, 
Boston, MA
Background: Cardiac troponin (Tn) T and I elevations are powerful independent prog-
nostic indicators in the setting of acute coronary syndrome (ACS). However, in clinical
practice, seemingly “false positive” Tn's are common . Methods and Results: To evalu-
ate whether such patients are “false positives” and if there is clinical significance of an
elevated Tn, we evaluated the prognosis of ACS patients enrolled in TACTICS-TIMI-18
study according to the presence or absence of CAD on angiography and Tn status on
admission. In this study 1,372 patients underwent angiography. A subset of 455 patients
were Tn negative, and of those, 362 (79.6%) had significant CAD (>50%stenosis in one
or more vessel). Fifty-seven out of 917 patients (6.2%) with + TnT or I did not have signif-
icant CAD. The mean value of TnT in patients with angiographic CAD was 0.603 ng/ml
compared to 0.281 ng/ml in those without CAD (p=0.01). The mean value of TnI was 9.39
ng/ml in patients with CAD compared to 3.32 ng/ml ( in patients without CAD (p=0.005).
An outcome of death or reinfarction at 6 months is shown in table.
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Conclusions: Elevated troponin in ACS confers a significantly high risk for death or MI,
even among patients who are found to not have significant CAD. The mechanism of this
adverse outcome deserves further study, but these data suggest that all patients present-
ing with a clinical history of ACS and a positive troponin at presentation deserve early
and long-term aggressive preventive management.
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884-6 Incidence of Vulnerable Plaques in Humans: 
Assessment With 3-D Intravascular Palpography
Johannes A. Schaar, Evelyn Regar, Francesco Saia, Chris L. de Korte, Frits Mastik, 
Anton F. van der Steen, Patrick W. Serruys, Erasmus Medical Center, Rotterdam, The 
Netherlands, Interuniversity Cardiology Institute of the Netherlands, Utrecht, The 
Netherlands
Intravascular palpography (IP) can detect deformable thin-cap fibroatheroma with a high
sensitivity and specificity by measuring the strain of the plaque surface. These vulnerable
plaques show a typical high strain pattern. We hypothesized that it is possible to detect
vulnerable plaques in-vivo in human coronary arteries by scanning the coronary artery
for typical high strain patterns.
Method: IP was performed in 56 patients by using standard 20 MHz intravascular ultra-
sound catheters (Avanar, JOMED Inc). Analysis included the complete length of the ves-
sel. The population was divided into 3 groups: Patients with [1] antecedent (<24h)
myocardial infarction. (post MI) [2] unstable angina (ST depression, Troponin negative);
(unstable). [3] Stable angina (stable). Per patient one coronary artery was investigated.
Results: IP was successful performed in all patients. The number of typical strain pat-
terns reflecting the number of vulnerable plaques per coronary artery are given in the
table. There was a significant difference between the stable vs. unstable group (p<0.001)
and stable vs. post MI group (p<0.0001). No difference was seen between the unstable
group and post MI group (p<0.056). 
Conclusion:
IP can be used to assess the number vulnerable plaques in humans. This pilot study
revealed a clear association between clinical presentation and the amount of vulnerable
plaques. Additional validation has to be performed to assess the predictive value of the
technique to identify vulnerable patients.
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891-1 Enhanced External Counterpulsation Decreases Wave 
Reflection Amplitude and Reduces Left Ventricular 
Afterload and Systolic Stress in Patients With 
Refractory Angina
Wilmer W. Nichols, Randy W. Braith, Rahul Aggarwal, C. R. Conti, University of Florida, 
Gainesville, FL
Background: Myocardial ischemia is associated with increased arterial stiffness which
causes early return of reflected pressure waves from the lower body and augments aortic
systolic and pulse pressures and increases left ventricular afterload and myocardial oxy-
gen demand. The aim of this study was to determine if arterial properties and wave
reflection characteristics are altered after EECP treatment in patients with chronic stable
angina resistant to anti-anginal medication. Methods: High-fidelity radial artery pressure
waveforms were recorded non-invasively by applanation tonometry and ascending aortic
pressure waveforms generated using a mathematical transfer function. Twenty patients
(age 61±7.3 years) with refractory angina taking two or more anti-anginal drugs were
studied. Data were collected before and after 34 one-hour EECP sessions. Augmentation
index (AIa, index of aortic stiffness) and amplitude and timing of the reflected pressure
wave (index of myocardial oxygen demand) were calculated from the generated aortic
pressure waveform. Results: EECP caused a significant decline in AIa from 27±10 to
19±9.8% (p<0.02) and a delay in reflected wave travel time from 68±8.3 to 74±6.8 msec
(p<0.01). These modifications in wave reflection characteristics were associated with a
decline in reflected wave amplitude (from 13±7.2 to 9.0±7.0 mm Hg, p<0.01) and dura-
tion (from 189±34 to 174±40 msec, p<0.01) which caused a decrease in aortic systolic
(from 120±18 to 108±18 mm Hg, p<0.01) and pulse (from 48±15 to 41±16 mm
Hg,p<0.01) pressure. The average number of anginal episodes per week decreased from
7.1±6.0 to 1.1±1.2 (p<0.02) while heart rate, body weight and drug regimen did not
change during the course of the study. Conclusions: EECP treatment delays return of the
reflected pressure wave from the periphery to the heart, reduces its amplitude and,
therefore, decreases aortic blood pressure and systolic stress in patients with refractory
angina taking anti-anginal medication. These changes, which are likely due to decreased
arterial stiffness and pulse wave velocity of the muscular arteries in the legs, reduce myo-
cardial oxygen demand and decrease the number of anginal episodes.
10:45 a.m.
891-2 External Counterpulsation Therapy: Significant Clinical 
Improvement Without Electrophysiologic Remodeling
Charles A. Henrikson, Nisha Chandra-Strobos, Johns Hopkins Medical Institutions, 
Baltimore, MD
Background: External counterpulsation therapy (ECP) non-invasively improves coronary
flow, hemodynamics, and time to ischemia in patients with severe coronary artery dis-
ease (CAD). Other treatments with similar effects, e.g. left ventricular assist devices, pro-
mote electrophysiologic remodeling, with a narrowing of the QRS complex.
Methods: We studied 28 patients, who completed a 7 week 35 hour session of ECP, to
assess whether such therapy would also result in electrophysiological remodeling, espe-
cially if associated with clinical improvement. All patients had class II-III angina, imaging-
proven ischemia, and severe CAD.
Results: Of 28 patients, with mean age 62+/-13 years (mean +/-SD), 78% were male,
46% diabetic, 82% hypertensive, 60% had undergone angioplasty, and 67% bypass sur-
gery. The mean ejection fraction was 44% (range 25-60%). Following ECP, most patients
(82%) had at least a one full class improvement in their anginal pattern. In most patients,
there was substantial baseline conduction system disease present: a mean QRS of 105
+/- 19 msec. Of note, there was no significant change in heart rate, PR, QRS, or QTc
intervals before and after ECP in either clinical responders or non-responders. When
Tn neg,
no CAD
n=93
Tn pos
no CAD
n=57
Tn neg
CAD
n=362
Tn pos
CAD
n=860
p-value
Death 0% 1.75% 2.21% 4.07% 0.082
MI 0% 3.51% 4.42% 8.26% 0.003
death or MI 0% 5.26% 5.52% 11.16% <0.001
Stable Unstable Post MI
n (patients) 19 19 18
High strain spots 0.7 ± 0.5 1.7 ± 0.4 2.0 ± 0.8
